The 36-month beta value for KTRA is at 0.81. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for KTRA is 55.36M, and currently, shorts hold a 2.76% of that float. The average trading volume for KTRA on September 11, 2024 was 5.27M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
KTRA) stock’s latest price update
The stock of Kintara Therapeutics Inc (NASDAQ: KTRA) has increased by 2.37 when compared to last closing price of 0.17.Despite this, the company has seen a gain of 1.03% in its stock price over the last five trading days. prnewswire.com reported 2024-09-11 that SAN DIEGO , Sept. 11, 2024 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today provided a corporate and REM-001 clinical study update.
KTRA’s Market Performance
KTRA’s stock has risen by 1.03% in the past week, with a monthly drop of -8.48% and a quarterly drop of -7.28%. The volatility ratio for the week is 7.09% while the volatility levels for the last 30 days are 9.54% for Kintara Therapeutics Inc The simple moving average for the last 20 days is -9.58% for KTRA’s stock, with a simple moving average of -0.99% for the last 200 days.
KTRA Trading at -20.42% from the 50-Day Moving Average
After a stumble in the market that brought KTRA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -96.40% of loss for the given period.
Volatility was left at 9.54%, however, over the last 30 days, the volatility rate increased by 7.09%, as shares sank -3.52% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -40.97% lower at present.
During the last 5 trading sessions, KTRA rose by +0.11%, which changed the moving average for the period of 200-days by -48.06% in comparison to the 20-day moving average, which settled at $0.1955. In addition, Kintara Therapeutics Inc saw 4.42% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for KTRA
The total capital return value is set at -1.57. Equity return is now at value -192.23, with -131.55 for asset returns.
Currently, EBITDA for the company is -14.75 million with net debt to EBITDA at 0.68. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.04.
Conclusion
In conclusion, Kintara Therapeutics Inc (KTRA) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
